Abstract
Contrast media appear to be just as safe in children as they are in adults. The risk factors are the same and the same precautions should be taken. The main differences relate to differences in technique necessitated by differences in size, differences in relative body compartment size, growth, immature renal function, etc., as well as to limited published evidence on their use and safety. Not all agents are approved for use in children, but most of the nonapproved agents can be used off-label with the informed consent of the parents.
On behalf of the Pediatric working group of the European Society of Urogenital Radiology and the Uroradiology task force of the European Society of Pediatric Radiology. Members (alphabetic order): Avni F, Blickman J, Damasio B, Darge K, Lobo ML, Mentzel HJ, Ntoulia K, Ording-Mueller LS, Papadopoulou F, Riccabona M (chair), Vivier PH, Willi U.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ACR Manual on Contrast Media, version 8 (2012a) Contrast media in children, p 47–52 and p 79 http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/Contrast%20Manual/FullManual.pdf
ACR Manual on Contrast Media, version 8 (2012b) Table 4: management of acute reactions in children http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/Contrast%20Manual/FullManual.pdf
American College of Radiology—ACR (2012) 2012/Manual on Contrast Media v8—Contrast media in children. http://www.acr.org/Quality-Safety/Resources/Contrast-Manual
Ascenti G, Zimbaro G, Mazziotti S et al (2004) Harmonic US imaging of vesicoureteric reflux in children: usefulness of a second generation contrast agent. Pediatr Radiol 34:481–487
Baker JF, Kratz LC, Stevens GR, Wible JH (2004) Pharmacokinetics and safety of the MRI contrast agent Gadoversetamide injection in healthy pediatric subjects. Invest Radiol 39(6):334–339
Basu S, Kumar A, Das BK (2009) Accidental aspiration of barium sulphate in an infant. Pediatr Radiol 39:762
Berrocal T, Gaya F, Arjonilla A et al (2001) Vesicoureteral reflux: diagnosis and grading with echo-enhanced cystosonography versus voiding cystourethrography. Radiology 221:359–365
Berrocal T, Gaya F, Arjonilla A (2005) Vesicoureteral reflux: can the urethra be adequately assessed by using contrast-enhanced voiding US of the bladder? Radiology 234:235–241
Brasch RC (2008) Contrast media toxicity in children. Pediatr Radiol 38(Suppl 2):S281–S284
Calliada F, Campani R, Bottinelli O et al (1998) Ultrasound contrast agents: basic principles. Eur J Radiol 27(Suppl 2):S157–S160
Claudon M, Cosgrove D, Albrecht T et al (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)—update 2008. Ultraschall Med 29:28–44
Correas JM, Bridal L, Lesavre A et al (2001) Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 11:1316–1328
Darge K, Troeger J (2002) Vesicoureteral reflux grading in contrast-enhanced voiding urosonography. Eur J Radiol 43:122–128
Darge K (2008) Voiding urosonography with ultrasound contrast agents for the diagnosis of vesicoureteric reflux in children. I—Procedure, and II—Comparison with radiological examinations. Pediatr Radiol 38: 40–53, 54–63
Darge K (2010) Voiding urosonography with US contrast agent for the diagnosis of vesicoureteric reflux in children: an update. Pediatr Radiol 40:956–962
Darge K (2011) CEUS task force of the society for pediatric radiology. Contrast-enhanced US (CEUS) in children: ready for prime time in the United States. Pediatr Radiol 41:1486–1488
Darge K, Papadopoulou F, Ntoulia A et al (2013) Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr Radiol 43:1063–1073
Dawson P, Becker A, Holton JM (1983) The effect of contrast media on the growth of bacteria. Brit J Radiol 56:809–815
Dharnidharka VR, Wesson SK, Fennell RS (2007) Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 22:1395
Duran C, Valera A, Alguersuari A et al (2009) Voiding urosonography: the study of the urethra is no longer a limitation of the technique. Pediatr Radiol 39:124–131
Eklöf O, Hald J, Thomasson B (1983) Barium peritonitis. Experience of five pediatric cases. Pediatr Radiol 13:5–9
Eldevik PO, Brunberg JA (1994) Gadopentetate Dimeglumine—enhanced MRI of the brain: clinical ultility and safety in patients younger than two years of age. Am J Neuroradiol 15:1001–1008
Esposito F, Di Serafino M, Sgambati P et al (2012) Ultrasound contrast media in paediatric patients: is it an off-label use? Regulatory requirements and radiologist’s liability. Radiol Med 117:148–159
Filler G, Yasin A, Medeiros M (2013) Methods of assessing renal function. Pediatr Nephrol. PMID: 23417278
Forsting M, Palkowitch P (2010) Prevalence of acute adverse reactions to gadobutrol—a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials. Eur J Radiol 74:186–190
Foss C, Smith JK, Ortiz L et al (2009) Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy. Pediatr Dermatol 26:579–582
Frush DP (2008) Pediatric abdominal CT angiography. Pediatr Radiol 38(Suppl 2):S259–S266
Hahn G, Sorge I, Gruhn B, Glutig K et al (2009) Pharmacokinetics and safety of gadobutrol-enhanced magnetic resonance imaging in pediatric patients. Invest Radiol 44(12):776–783
Hammer GP, Seidenbusch MC, Regulla DF et al (2011) Childhood cancer risk from conventional radiographic examinations for selected referral criteria: results from a large cohort study. AJR Am J Roentgenol 197:217–223
Heran MK, Marshalleck F, Temple M et al (2010) Society of interventional radiology standards of practice committee; society of pediatric radiology interventional radiology committee. Joint quality improvement guidelines for pediatric arterial access and arteriography: from the societies of interventional radiology and pediatric radiology. Pediatr Radiol 40:237–250
Hernanz-Schulman M, Foster C, Maxa R et al (2000) Experimental study of mortality and morbidity of contrast media and standardized fecal dose in the peritoneal cavity. Pediatr Radiol 30:369–378
Hiorns MP (2011) Gastrointestinal tract imaging in children: current techniques. Pediatr Radiol 41:42–54
Hocine N, Berry JP, Jafoura H et al (1995) Subcellular localization of gadolinium injected as soluble salt in rats: a microanalytical study. Cell Mol Biol (Noisy-le-grand) 41:271–278
Idée JM, Port M, Raynal I et al (2006) Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20:563–576
Jain SM, Wesson S, Hassanein A et al (2004) Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 19:467–470
Kao SC, Franken EA Jr (1995) Nonoperative treatment of simple meconium ileus: a survey of the Society for Pediatric Radiology. Pediatr Radiol 25:97–100
Karcaaltincaba M, Oguz B, Haliloglu M (2009) Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children. Pediatr Radiol 39(Suppl 3):S382–S384
Kenda RB, Novljan G, Kenig A et al (2000) Echo-enhanced ultrasound voiding cystography in children: a new approach. Pediatr Nephrol 14:297–300
Krille L, Zeeb H, Jahnen A et al (2012) Computed tomographies and cancer risk in children: a literature overview of CT practices, risk estimations and an epidemiologic cohort study proposal. Radiat Environ Biophys 51:103–111
Kurian J, Epelman M, Darge K et al (2013) The role of CT angiography in the evaluation of pediatric renovascular hypertension. Pediatr Radiol 43:490–501
Langlois V (2008) Laboratory evaluation at different ages. In: Geary DF, Schaefer F (eds) Comprehensive pediatric nephrology. Mosby, Elsevier, Philadelphia. pp 39–54
Leonidas JC, Burry VF, Fellows RA, Beatty EC (1976) Possible adverse effect of methylglucamine diatrizoate compounds on the bowel of newborn infants with meconium ileus. Radiology 121:693–696
Mannelli L, Maki JH, Osman SF et al (2012) Noncontrast functional MRI of the kidneys. Curr Urol Rep 13:99–107
McAlister WH, Siegel MJ (1984) Fatal aspirations in infancy during gastrointestinal series. Pediatr Radiol 14:81–83
McCarville MB (2011) Contrast-enhanced sonography in pediatrics. Pediatr Radiol 41(Suppl 1):S238–S242
Mendichovszky IA, Marks SD, Simcock CM, Olsen OE (2008) Gadolinium and nephrogenic systemic fibrosis: time to tighten practice. Pediatr Radiol 38:489–496
Mikkonen R, Kontkanen T, Kivisaari L (1995) Late and acute adverse reactions to Iohexol in a pediatric population. Pediatr Radiol 35:350–352
Morcos SK. (2007) Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? Br J Radiol 80:73–76 (Erratum in: Br J Radiol 2007; 80:586)
Morel DR, Schwieger I, Hohn L et al (2000) Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 35:80–85
Nolsoe C, Piscaglia F, Dietrich CF et al (2011) Primum non nocere? Why can’t we use second generation ultrasound contrast agents for the examination of children? Ultraschall Med 32:83–86
Ntoulia K, Darge K, Riccabona M (2013) Contrast-enhanced US of the childs’ urinary tract revisited. Pediatr Radiol (in press)
Papadopoulou F, Evangelou E, Riccabona M et al (2012) Contrast-enhanced voiding urosonography for diagnosis of vesico-ureteric reflux in comparison to conventional methods: a meta-analysis. ECR Book of abstracts, Insights Imaging 3(Suppl 1, SS 1712):B-0860
Pärtan G (2013) Radiography and Fluoroscopy. In: Riccabona M (ed) Pediatric imaging essentials: X-ray, ultrasound, CT and MRI in neonates and children. Thieme Stuttgart (in press)
Pearce MS, Salotti JA, Little MP et al (2012) Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 380:499–505
Penfield JG, Reilly RF (2008) Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents? Semin Dial 21:129–134
Persson P (2011) Personal communication. ESUR meeting, Dubrovnik
Piscaglia F, Bolondi L (2006) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32:1369–1375
Piscaglia F, Nolsøe C, Dietrich CF et al (2012) The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33:33–59
Piskunowicz M, Kosiak W, Irga N (2011) Primum non nocere? Why can’t we use second generation ultrasound contrast agents for the examination of children? Ultraschall Med 32:83–86
Piskunowicz M, Kosiak W, Batko T (2012) Intravenous application of second-generation ultrasound contrast agents in children: a review of the literature. Ultraschall Med 33:135–140
Riccabona M, Olsen OE, Claudon M et al (2008a) Gadolinium and nephrogenic systemic fibrosis. In: Fotter R (ed) Pediatric uroradiology. Springer, Berlin-Heidelberg, pp 317–513
Riccabona M, Avni FE, Blickman JG et al (2008b) Imaging recommendations in pediatric uroradiology: minutes of the ESPR working group session on urinary tract infection, fetal hydronephrosis, urinary tract ultrasonography and voiding cystourethrography, Barcelona, Spain, June 2007. Pediatr Radiol 38:138–145
Riccabona M, Avni FE, Blickman JG et al (2009) (Members of the ESUR pediatric recommendation working group and ESPR pediatric uroradiology working group). Imaging recommendations in paediatric uroradiology, part II: urolithiasis and haematuria in children, paediatric obstructive uropathy, and postnatal work-up of fetally diagnosed high grade hydronephrosis. Minutes of a mini-symposium at the ESPR annual meeting, Edinburgh June. Pediatr Radiol 39:891–898
Riccabona M, Avni FE, Dacher JN et al (2010) ESPR uroradiology task force and ESUR pediatric working group: imaging and procedural recommendations in pediatric uroradiology, part III. Minutes of the ESPR uroradiology task force minisymposium on intravenous urography, uro-CT and MR-urography in childhood. Pediatr Radiol 40:1315–1320
Riccabona M (2012) Application of a second-generation US contrast agent in infants and children—a European questionnaire-based survey. Pediatr Radiol 42:1471–1480
Ring E, Riccabona M, Fotter R (2008) Normal values, laboratory values. In: Fotter R (ed) Pediatric uroradiology. Springer, Heidelberg, pp 508–510
Schreiber-Dietrich D, Dietrich CF (2012) Contrast enhanced ultrasound (CEUS) and off-label use (in children). Ultraschall Med 33:295–296
Schwartz GJ, Haycock GB, Spitzer A (1976) Plasma creatinine and urea concentration in children. Normal values for age and sex. J Pediatr 88:830–928
Schwartz GJ, Work DF (2008) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843
Schwartz GJ, Munoz A, Schneider MF et al (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637
Sorantin E, Zsivcsec B, Zebedin D, Fotter R (2002) Optimierung von i.v. Kontrastmittelapplikatonen für pädiatrische spiral-CT Untersuchungen (Optimisation of i.v. contrast application for pediatric spiral-CT). Radiologe 45:683–684
Sorantin ES, Weissensteiner S, Hasenburger G, Riccabona M (2013a) CT in children—dose protection and general considerations when planning a CT in a child. Eur J Radiol 82:1043–1049
Sorantin E (2013b) Special aspects of computed tomography in children. In: Riccabona M (ed) Pediatric imaging essentials: X-ray, Ultrasound, CT and MRI in neonates and children. Thieme—Stuttgart (in press)
Speck U (1999) Kontrastmittel Übersicht, Anwendung und pharmazeutische Aspekte. Springer, Berlin, pp 16–17
Taylor GA (2000) Potential pediatric applications for US contrast agents: lessons from the laboratory. Pediatr Radiol 30:101–109
ter Haar G (2009) Safety and bio-effects of ultrasound contrast agents. Med Biol Eng Comput 47:893–900
Thomsen HS, Morcos SK, Almen T et al (2013) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 23:307–318
Torzilli G (2005) Adverse effects associated with SonoVue use. Expert Opin Drug Saf 4:399–401
Valentini AL, De Gaetano AM, Destito C et al (2002) The accuracy of voiding urosonography in detecting vesico-ureteral reflux: a summary of existing data. Eur J Pediatr 161:380–384
Williams SM, Harned RK (1991) Recognition and prevention of barium enema complications. Curr Probl Diagn Radiol 20:123–151
Zerin JM (1992) Contrast studies of the gastrointestinal tract in the neonate. Semin Pediatr Surg 1:284–295
Zimbaro G, Ascenti G, Visalli C et al (2007) Contrast-enhanced ultrasonography (voiding urosonography) of vesicoureteral reflux: state of the art. Radiol Med 112:1211–1224
Zoo M, Hoermann M, Balassy C et al (2011) Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT. Pediatr Radiol 41:1393–1400
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Riccabona, M. (2014). Contrast Media Use in Pediatrics: Safety Issues. In: Thomsen, H., Webb, J. (eds) Contrast Media. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2013_901
Download citation
DOI: https://doi.org/10.1007/174_2013_901
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36723-6
Online ISBN: 978-3-642-36724-3
eBook Packages: MedicineMedicine (R0)